Skip to content

Pain Education and Therapeutic Exercise for Fibromyalgia

Effects of Pain Education and Therapeutic Exercise for Patients With Fibromyalgia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03641495
Enrollment
32
Registered
2018-08-22
Start date
2018-09-03
Completion date
2019-01-30
Last updated
2021-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

fibromyalgia, therapeutic exercise, physiotherapy

Brief summary

Fibromyalgia syndrome is characterized by chronic generalized musculoskeletal pain associated with fatigue, sleep disturbances and psychological problems. The European League Againts Rheumatism (EULAR) described an algorithm how to treat step by step these patients. The objective of this trial is to evaluate if patient education plus therapeutic exercise is more effective in pain intensity, fatigue, function, strength, pain threshold, anxiety, depression, quality of life, quality of sleep, kinesiophobia, pain coping and biochemical and genetic markers and compared to therapeutic exercise. For this purpose the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of fibromyalgia according to the American College of Rheumatology (ACR). Patients included are randomized into 2 groups one receive education of pain neurophysiology plus exercise therapy and the other only exercise therapy. Groups receive 3 treatment sessions a week over 10 weeks. The variables are measured at the beginning and end of treatment. And also some variables are measured before and after each session.

Interventions

OTHERPE+ET

To explain the physiology of nervous system and the mechanism and modulation of acute and chronic pain. To perform different whole body aerobic exercises with a mild to moderate intensity according to Borg scale and maximum heart rate.

OTHERET

To perform different whole body aerobic exercises with a mild to moderate intensity according to Borg scale and maximum heart rate.

Sponsors

University of Valladolid
CollaboratorOTHER
Universidad de Zaragoza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed medically with Fibromyalgia * Diagnosed according to the American College of Rheumatology criteria * Agreement to attend to treatment sessions

Exclusion criteria

* Any kind of contraindications for physical activity * Other kind of diseases that could limit the intervention * Previous surgery last year * Medication modifications in the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Pain Intensity: VASBaselineThe investigators measure the intensity of pain with a Visual Analogic Scale (VAS) pre-intervention at baseline
Fibromyalgia Impact QuestionnaireBaselineThe investigators measure the impact of Fibromyalgia syndrome by Fibromyalgia Impact Questionnaire R (FIQ-R) pre-intervention at baseline

Secondary

MeasureTime frameDescription
Quality of Sleep: Pittsburg Sleeping Questionnairethrough study completion, an average 10 weeksThe investigators measure the quality of sleep with Pittsburg Sleeping Questionnaire Index (PSQI) at the end of the intervention
Functional CapacityBaselineThe investigators measure the functional capacity with Senior Fitness Test at baseline
body strengthbaselineThe investigators measure the strength of arms with handgrip test, elbow flexion and knee extension with handheld dynamometer at baseline
Pressure pain thresholdbaselineThe investigators measure the pressure pain threshold of the 18 points described initially by the American College of rheumatology with a digital algometer at baseline
FatigueBaselineThe investigators measure the fatigue with Multidimensional Fatigue Inventory (MFI-S) pre-intervention at baseline
kinesiophobiabaselineThe investigators measure the kinesiophobia with TAMPA questionnaire at baseline
Quality of life: HAQbaselineThe investigators measure the quality of life with Health Assessment Questionnaire (HAQ) at baseline
Central sensitizationbaselineThe investigators measure the central sensitization with Chronic Pain Self-Efficacy Scale (CPSS) at baseline
Anxiety and DepressionBaselineThe investigators measure the anxiety and depression with Hospital Anxiety and Depression Scale (HADS) at baseline
Quality of SleepBaselineThe investigators measure the quality of sleep with Pittsburg Sleeping Questionnaire Index (PSQI) at baseline

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026